Institute for International Research

Dear Colleague,

Studies show that it can cost as little as $9 million to repurpose a known compound or marketed drug, but up to twelve times as much to discover and launch a drug. These “new” economic forces are driving pharmaceutical companies to make opportunistic moves to pursue new commercial opportunities for known compounds and drugs.

As pharma revenues continue to be eroded by generic entry, the product pipelines of pharma companies are getting thinner and compounds face more safety and regulatory hurdles to approve compounds amid rising development costs. In times like these, “drug repurposing” business strategies have grown to become important ways to enhance and advance product pipelines by focusing on new markets for known compounds.

IIR is pleased to assemble the most important experts for our Drug Repurposing meeting to give you full access to the best practices and interactive discussions to help navigate through the commercial opportunities behind repurposing these new compounds.

This meeting offers detailed insights as industry thought leaders share strategies, technologies, and tools to reposition marketed or reformulated compounds.

• Fast forward your plans to repurpose drug and boost your pipeline
• Benefit from an exceptional speaking faculty who will provide solutions and strategies that you can implement to help reach maximum repurposing potential
• Explore the current and future potential of genetic and biomarker strategies in de novo drug development, and for the repurposing of existing drugs and molecular libraries
• Find out how novel (controlled release and targetable) drug delivery systems increase the marketability of drugs
• Learn how kinetic biomarkers can identify new indications of drugs and predict clinical response
• Overcome intellectual property challenges to patents and marketing exclusivity
• Uncover the current obstacles through case examples to discover the right solution for you

This meeting is a great investment. Take advantage of this fantastic two day meeting to interact with repositioning and repurposing experts, network with colleagues, and develop relationships with industry professionals. Reduce cost and risk while filling pipelines with products that have a higher level of success and potentially a faster FDA approval track.

We look forward to welcoming you January 22nd in Las Vegas!